Because multiple tumor antigens, including carcinoembryonic antigen (CEA) and survivin
(SVV), have been frequently observed in human colorectal cancer, we investigated whether …

Carcinoembryonic antigen (CEA), which is expressed in several cancer types, is a potential
target for specific immunotherapy. In this study, the feasibility of using dendrite cells (DCs) …

Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has
been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific …

Carcinoembryonic antigen (CEA) is a cancer vaccines' target. Several features of
recombinant adeno-associated virus (rAAV) are attractive for vaccine applications …

Carcinoembryonic antigen (CEA) is expressed on human colon carcinomas, is well
characterized, and continues to be a promising target for cancer immunotherapy in humans …

This study was designed to determine whether the vaccination of genetically modified
dendritic cells (DCs) simultaneously expressing carcinoembryonic antigen (CEA) …

Transduction with recombinant, replication-defective adenovirus (AdV) vectors encoding a
transgene is an efficient method for gene transfer into murine or human dendritic cells (DC) …

Several studies have shown that vaccine therapy using dendritic cells (DCs) pulsed with
specific tumor antigen peptides can effectively induce antitumor immunity. Peptide-pulsed …

Human colon cancers express carcinoembryonic antigen (CEA). Thus, CEA has been
considered as a potential vaccine target for immune therapy against colon cancer. In this …

Immunization with specific tumor-associated antigen (Ag)(TAA)-pulsed dendritic cells (DC)
has proven to be eficacious in a variety of animal models and is being investigated for the …